Preclinical studies indicate that GLP-1 receptor agonists reduce not just alcohol intake, but also nicotine self-administration and nicotine-related reward,'' Hendershot noted. However ...

“We are proud to introduce SAFER, a package of proven interventions to reduce the harms caused by alcohol” said Dr Adhanom Ghebreyesus, chief of WHO The World Health Organization ...

Angela Hulstone, Lead Alcohol Liaison Nurse at UHNM said: “Alcohol increases your risk of cancer, particularly bowel and ...

Phase 2 trial shows significant reduction in drinks per drinking day and weekly alcohol craving. (HealthDay News) — Low-dose semaglutide seems to reduce craving and certain drinking outcomes in ...